Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1998-10-05
2000-02-22
Budens, Robert D.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241331, 4241341, 4241351, 5303873, A61K 39395, C07K 1600, C07K 1644, C07K 1646
Patent
active
060277254
ABSTRACT:
Compositions of, genetic constructions coding for, and methods for producing multivalent antigen-binding proteins are described and claimed. The methods include purification of compositions containing both monomeric and multivalent forms of single polypeptide chain molecules, and production of multivalent proteins from purified monomers. Production of multivalent proteins may occur by a concentration-dependent association of monomeric proteins, or by rearrangement of regions involving dissociation followed by reassociation of different regions. Bivalent proteins, including homobivalent and heterobivalent proteins, are made in the present invention. Genetic sequences coding for bivalent single-chain antigen-binding proteins are disclosed. Uses include all those appropriate for monoclonal and polyclonal antibodies and fragments thereof, including use as a bispecific antigen-binding molecule.
REFERENCES:
patent: 4085443 (1978-04-01), Dubois et al.
patent: 4266253 (1981-05-01), Matherat
patent: 4355023 (1982-10-01), Ehrlich et al.
patent: 4414629 (1983-11-01), Waite
patent: 4434156 (1984-02-01), Trowbridge
patent: 4444878 (1984-04-01), Paulus
patent: 4470925 (1984-09-01), Auditore-Hargreaves
patent: 4479895 (1984-10-01), Auditore-Hargreaves
patent: 4642334 (1987-02-01), Moore et al.
patent: 4704692 (1987-11-01), Ladner
patent: 4816397 (1989-03-01), Boss et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4853871 (1989-08-01), Pantoliano et al.
patent: 4861581 (1989-08-01), Epstein et al.
patent: 4881175 (1989-11-01), Ladner et al.
patent: 4908773 (1990-03-01), Pantolliano et al.
patent: 4939666 (1990-07-01), Hardman
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5019368 (1991-05-01), Epstein et al.
patent: 5091513 (1992-02-01), Huston et al.
patent: 5132405 (1992-07-01), Huston et al.
patent: 5160723 (1992-11-01), Weit et al.
patent: 5258498 (1993-11-01), Huston et al.
patent: 5260203 (1993-11-01), Ladner et al.
patent: 5476786 (1995-12-01), Huston
patent: 5534254 (1996-07-01), Huston et al.
patent: 5591828 (1997-01-01), Bosslet et al.
patent: 5763733 (1998-06-01), Whitlow et al.
patent: 5767260 (1998-06-01), Whitlow et al.
patent: 5844094 (1998-12-01), Hudson et al.
LeBerthon, B. et al., "Enhanced Tumor Uptake of Macromolecules Induced by a Novel Vasoactive Interleukin 2 Immunoconjugate," Cancer Research 51(10):2694-2698 (May 15, 1991).
Gillies, S.D. et al., "Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells," Proc. Natl. Acad. Sci. USA 69(4):1428-1432 (Feb. 1992).
Batra, J.K., et al., "Anti-Tac(Fv)-PE40, a Single Chain Antibody Pseudomonas Fusion Protein Directed at Interleukin 2 Receptor Bearing Cells," J. Biol. Chem. 265:15198-15202 (Sep. 1990).
Breitling, F., et al., "A surface expression vector for antibody screening," Gene 104:147-153 (Aug. 1991).
Chaudhary, V.J., et al., "A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin," Nature 339:394-397 (Jun. 1989).
Clements, J.D., "Construction of a Nontoxic Fusion Peptide for Immunization against Escherichia coli Strains That Produce Heat-Labile and Heat-Stable Enterotoxins," Infect. Immun. 58:1159-1166 (May 1990).
Condra, J.H., et al., "Bacterial Expression of Antibody Fragments That Block Human Rhinovirus Infection of Cultured Cells," J. Biol. Chem. 265:2292-2295 (Feb. 1990).
Essig, N.Z., et al., "Crystallization of Single-Chain Fv Proteins," J. Mol. Biol. 234:897-901 (Dec. 1993).
Fuchs, P., et al., "Targeting Recombinant Antibodies To The Surface of Escherichia coli: Fusion To A Peptidoglycan Associated Lipoprotein," Bio/Technol. 9:1369-1372 (Dec. 1991).
Harris, W.J., and Emery, S., "Therapeutic antibodies--the coming of age," TiBTech 11:42-44 (Feb. 1993).
Hird, V., and Epenetos, A.A., "Immunotherapy with Monoclonal Antibodies" in: Genes and Cancer, Carney, D., and Sikora, K., eds., John Wiley & Sons Ltd., pp. 183-189 (1990).
Holvoet, P., et al., "Characterization of a Chimeric Plasminogen Activator Consisting of a Single-Chain Fv Fragment Derived from a Fibrin Fragment D-Dimer-specific Antibody and a Truncated Single-chain Urokinase," J. Biol. Chem. 266:19717-19724 (Oct. 1991).
Huston, J.S., et al., "Medical Applications of Single-Chain Antibodies," Int. Rev. Immunol 10:195-217 (1993).
Kim, S.-H., et al., "Redesigning a sweet protein: increased stability and renaturability," Protein Eng. 2:571-575 (Aug. 1989).
Laroche, Y., et al., "Characterization of a Recombinant Single-chain Molecule Comprising the Variable Domains of a Monoclonal Antibody Specific for Human Fibrin Fragment D-dimer," J. Biol. Chem. 266:16343-16349 (Sep. 1991).
Lehninger, A.L., in: Principles of Biochemistry, Worth Publishers, Inc., New York, pp. 150-155 (1982).
Milenic, D.E., et al., "Construction, Binding Properties, Metabolism, and Tumor Targeting of a Single-Chain Fv Derived from the Pancarcinoma Monoclonal Antibody CC49," Cancer Res. 51:6363-6371 (Dec. 1991).
Mottez, E., et al., "A single-chain murine class I major transplantation antigen," Eur. J. Immunol. 21:467-471 (Feb. 1991).
Novotny, J., et al., "A soluble, single-chain T-cell receptor fragment endowed with antigen-combining properties," Proc. Natl. Acad. Sci. USA 88:8646-8650 (Oct. 1991).
Schlom, J., "Monoclonal Antibodies: They're More and Less Than You Think" in: Molecular Foundations of Oncology, Broder, S., ed., Williams & Wilkins, Baltimore, MD, pp. 95-134 (1991).
Seehaus, T., et al., "A vector for the removal of deletion mutants from antibody libraries," Gene 114:235-237 (May 1992).
Soo Hoo, W.F., et al., "Characterization of a single-chain T-cell receptor expressed in Escherichia coli," Proc. Natl. Acad. Sci. USA 89:4759-4763 (May 1992).
Takkinen, K., et al., "An active single-chain antibody containing a cellulase linker domain is secreted by Escherichia coli," Protein Eng. 4:837-841 (Oct. 1991).
Welt, S., et al., "Quantitative Analysis of Antibody Localization in Human Metastatic Colon Cancer: A Phase I Study of Monoclonal Antibody A33," J. Clin. Oncol. 8:1894-1906 (Nov. 1990).
Whitlow, M., et al., "An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability," Protein Eng. 6:989-995 (Nov. 1993).
Whitlow, M., and Filpula, D., "Single Chain Fvs," in: Tumor Immunology: A Practical Approach, Oxford University Press, pp. 279-291 (1993).
Wootton, J.C., and Drummond, M.H., "The Q-linker: a class of interdomain sequences found in bacterial multidomain regulatory proteins," Protein Eng. 2:535-543 (May 1989).
Yokota, T., et al., "Rapid Tumor Penetration of a Single-Chain Fv and Comparison with Other Immunoglobulin Forms," Cancer Res. 52:3402-3408 (Jun. 1992).
"Nothing to lose but their chains," The Economist (Feb. 27, 1988).
Ahlem, et al., "Regiospecific Coupling of FAB' Fragments for the Production of Synthetic Bifunctional Antibodies," Targeted Cellular Cytotoxicity and Biospecific Antibodies, Annapolis, MD, Poster No. 18 (Oct. 22-25, 1989).
Aldred, et al., "Synthesis of rat transferrin in Escherichia coli containing a recombinant bacteriophage," Chem. Abstracts 101:189 Abstract No. 185187m (1984).
Andrew, et al., "Production of a Single Chain Bispecific Antibody by Recombinant DNA Technology," Second Intl. Conf. on Bispecific Antibodies and Targeted Cellular Cytotox., Seillac, France, Poster No. 21 (Oct. 9-13, 1990).
Aussage, et al., "Bispecific Heteroconjugate of Anti-HB's and Anti-Fc .gamma. RI Prepared by SPDP Method: Production and Bispecificity Analysis," Second Intl. Conf. on Bispecific Antibodies and Targeted Cellular Cytotox., Seillac, France, Poster No. 41 (Oct. 9-13, 1990).
Bedzyk, et al., "Immunological and Structural Characterization of a High Affinity Anti-fluorescein Single-chain Antibody," J. Biol. Chem. 265(30):18615-18620 (Oct. 1990).
Bird, et al., "Single-Chain Antigen-Binding Proteins," Science 242:423-426 (Oct. 1988).
Bishop, J.E., "Proteins Made by Genex Could Compete With Far Larger Monoclonal Antibodies," The Wall Street Journal (Oct. 21, 1988).
Boss, et al., "Assembly of functional antibodies from immunoglobulin heavy and light chains synt
Bird Robert E.
Filpula David
Hardman Karl D.
Rollence Michele
Whitlow Marc D.
Budens Robert D.
Enzon Inc.
LandOfFree
Multivalent antigen-binding proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multivalent antigen-binding proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multivalent antigen-binding proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-518139